Who we are

QuantuMDx Group is a young and vibrant medical devices company developing hand-held and portable
low cost diagnostic, genomic sequencing & proteomic platforms capable of supporting the delivery of personalised medicine across both developed and developing nations.

Our focus is to develop simple, easy to use devices that not only deliver rapid & accurate - sample to result - medical diagnosis for complex diseases within minutes at the patient’s side, but can integrate with mobile apps for ongoing support and education of patients.

Our first commercial product, due out in 2013, will be the Q-POC™, QuantuMDx’s hand-held point of care platform, with first commercial assays in companion diagnostics and multi-drug resistant infectious disease testing (including TB, HIV and STIs).

Products in development include Q-SEQ™, a portable genomic sequencer, and InVenio™, a whole proteome array.